Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer: A Feasibility Study

NCT06889467 is registered in ClinicalTrials.gov with Barzilai Medical Center as lead sponsor.

NCT NCT06889467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06889467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer: A Feasibility Study
Lead sponsor
Barzilai Medical Center
Phase
Observational
Overall status
Recruiting
Start date
January 20, 2025
Completion date
December 31, 2025
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (nsclc), lung cancer - non small cell, non small cell lung cancer, non small cell lung cancer (nsclc), pulmonary nodule